Skip to main content
Skip to section navigation
Skip to footer
About Us
Company Overview
Management
Board of Directors
Pipeline
Pipeline Overview
Paxalisib
PD-L1 Protein Degrader
SETDB1 Inhibitor
EVT801
Clinical Trials
Posters & Publications
Technology
Media Center
Media Center Overview
News
Events
In The News
Video Gallery
ASX Announcements
Investors
Investors Overview
News & Events
Company Info
Financial Results
Stock Data
SEC Filings
Governance
ASX Delisting
Contact Us
Governance Documents
Investors
Investors
Investors Overview
News & Events
Press Releases
IR Calendar
Presentations
Annual General Meeting
Email Alerts
Company Info
Company Profile
Management
Contacts
FAQ
Financial Results
Stock Data
Quote & Chart
Historical Data
SEC Filings
All SEC Filings
Annual Reports
Section 16 Filings
Governance
Governance Overview
Board of Directors
Board Committees
Governance Documents
ASX Delisting
Conversion How-to
Corporate Documents
Code of Business Conduct and Ethics
Download
Constitution
Download
Values Statement
Download
Corporate Governance Disclosure Pursuant to NASDAQ Rule 5615(a)(3)
Download
Policies
Anti-Corruption Compliance Policy
Download
Continuous Disclosure Policy
Download
Employee Share Option Plan
Download
Expanded Access Policy
Download
Securities Trading Policy
Download
Shareholder Communications Policy
Download
Whistleblower Policy
Download
Charters
Board Charter
Download
Audit, Risk, and Governance Committee Charter
Download
Remuneration and Nomination Committee Charter
Download
email
Email Alerts
location_city
Company Profile
contact_page
Contacts
rss_feed
RSS News Feed